FIELD: medicine.
SUBSTANCE: group of inventions relates to oncology, and can be used for treating a human subject having a tumour. That is ensured by administering M1 alphavirus to the subject. Tumour is a tumour with low ZAP expression or ZAP-negative tumour in a human. Also disclosed is an anticancer agent containing M1 alphavirus and ZAP inhibitor.
EFFECT: group of inventions provides treating human tumours with low expression of ZAP or ZAP-negative tumours.
21 cl, 3 tbl, 5 dwg, 6 ex
| Title |
Year |
Author |
Number |
| ADENOVIRUS/ALFAVIRUS HYBRID VECTOR FOR EFFECTIVE ADMINISTRATION AND EXPRESSION OF THERAPEUTIC GENES IN TUMOR CELLS |
2005 |
- Tsjan' Chehn
- Guan' Min'
- Smerdou Pikazo Kristian
- Pr'Eto Val'Tuehn'Ja Khesus
|
RU2394104C2 |
| ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX |
2017 |
|
RU2742726C2 |
| RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT |
2012 |
- Li, Sang Dzin
- Kim,Jun Khee,
- Kim,In Khoo
- Choi,Kiung Kho
- Chun,Kiung-Khee
|
RU2575620C2 |
| ANTI-CANCER TARGETED IMMUNOTHERAPY WITH APPLICATION OF IL-12 |
2015 |
- Shrittmatter Volfgang
- Khandgretinger Rupert
- Shilbakh-Shtyukle Karin
|
RU2689160C2 |
| METHODS AND COMPOSITIONS FOR TUSC2-IMMUNOTHERAPY |
2017 |
|
RU2755903C2 |
| ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS |
2009 |
- Khemminki Akseli
- Kanerva Anna
- Cherullo Vinchentso
- Pesonen Sari
|
RU2520823C2 |
| DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS |
2014 |
- Sakhin Ugur
- Tyurechi Ozlem
- Valter Korden
- Vagner Majke
- Krojtsberg Mariya
- Kheker Sabine
- Yakobs Shtefan
|
RU2749867C2 |
| METHOD OF IN VITRO DETERMINATION OF PROGNOSIS OF DISEASE DEVELOPMENT IN PATIENT WITH CANCER AND METHOD OF IN VITRO MONITORING EFFECT OF THERAPY ADMINISTERED TO PATIENT WITH CANCER |
2006 |
- Lakal' Sankhuan Khuan Karlos
- Ramires De Molina Ana
- Gallego Ortega David
- Ban'Es Koronel' Monika
|
RU2434946C2 |
| IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS |
2011 |
- Gunn Harold David
- Dhanji Salim
|
RU2722357C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HDAC INHIBITOR AND ANTI-PD1 ANTIBODY OR ANTI-PD-L1 ANTIBODY |
2020 |
- Kim, Yung-De
- Chkho, Choon Myun
|
RU2824577C1 |
